Committed to the development of innovative therapies for human and veterinary oncology applications, we are currently developing our main drug candidate ET-D5 for both applications simultaneously. In addition, we have several other R&D programs currently in the discovery phase.
Developing innovative therapies to improve patient life is our primary mission. We care about you.
Our technology platform
We use our proprietary phenotypic screening platform to discover new effective drugs.